BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36905333)

  • 21. Impact of lymphatic and/or blood vessel invasion in stage II gastric cancer.
    Du CY; Chen JG; Zhou Y; Zhao GF; Fu H; Zhou XK; Shi YQ
    World J Gastroenterol; 2012 Jul; 18(27):3610-6. PubMed ID: 22826628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor downstaging after neoadjuvant chemotherapy determines survival after surgery for gastric adenocarcinoma.
    Levenson G; Voron T; Paye F; Balladur P; Debove C; Chafai N; De Dios AG; Lefevre JH; Parc Y
    Surgery; 2021 Dec; 170(6):1711-1717. PubMed ID: 34561115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Implications of Tumor Differentiation in Clinical T1N0 Gastric Adenocarcinoma.
    Margalit O; Shacham-Shmueli E; Yang YX; Lawerence YR; Levy I; Reiss KA; Golan T; Halpern N; Aderka D; Giantonio B; Mamtani R; Boursi B
    Oncologist; 2021 Jan; 26(1):e111-e114. PubMed ID: 32969129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inaccurate pretreatment staging can impact survival in early stage esophageal adenocarcinoma.
    Scholer AJ; Uppal A; Chang SC; Ghosh D; Garland-Kledzik M; Santamaria-Barria J; Khader A; Dehal A; Fischer T; Goldfarb M
    J Surg Oncol; 2020 Oct; 122(5):914-922. PubMed ID: 32632944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perioperative chemotherapy for resectable gastroesophageal cancer: a single-center experience.
    Molina R; Lamarca A; Martínez-Amores B; Gutiérrez A; Blázquez A; López A; Granell J; Álvarez-Mon M
    Eur J Surg Oncol; 2013 Aug; 39(8):814-22. PubMed ID: 23755989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Staging of adenocarcinoma of the esophagogastric junction: comparison of AJCC 6th and 7th gastric and 7th esophageal staging systems.
    Kim HI; Cheong JH; Song KJ; An JY; Hyung WJ; Noh SH; Kim CB
    Ann Surg Oncol; 2013 Aug; 20(8):2713-20. PubMed ID: 23456315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcomes after radical gastrectomy in gastric cancer patients with overt bleeding.
    Wang L; Wang XA; Hao JQ; Zhang LN; Li ML; Wu XS; Weng H; Lv WJ; Zhang WJ; Chen L; Xiang HG; Lu JH; Liu YB; Dong P
    World J Gastroenterol; 2015 Dec; 21(47):13316-24. PubMed ID: 26715815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prognostic value of different node staging systems in patients with ≤15 lymph nodes following surgery for gastric adenocarcinoma.
    Kılıç MÖ; Gündoğdu SB; Özden S; Saylam B; Tez M
    Acta Chir Belg; 2018 Feb; 118(1):1-6. PubMed ID: 28669280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrated cancer networks improve compliance with national guidelines and outcomes for resectable gastric cancer.
    Thiels CA; Hanson KT; Habermann EB; Boughey JC; Grotz TE
    Cancer; 2020 Mar; 126(6):1283-1294. PubMed ID: 31821545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of Positive Margins After Definitive Resection for Gastric Adenocarcinoma and Impact of Adjuvant Therapies.
    Rhome RM; Moshier E; Sarpel U; Ohri N; Mazumdar M; Buckstein MH
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1106-1115. PubMed ID: 28721894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant radiotherapy improves overall survival in patients with resected gastric adenocarcinoma: A National Cancer Data Base analysis.
    Stumpf PK; Amini A; Jones BL; Koshy M; Sher DJ; Lieu CH; Schefter TE; Goodman KA; Rusthoven CG
    Cancer; 2017 Sep; 123(17):3402-3409. PubMed ID: 28513823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction.
    Davies AR; Gossage JA; Zylstra J; Mattsson F; Lagergren J; Maisey N; Smyth EC; Cunningham D; Allum WH; Mason RC
    J Clin Oncol; 2014 Sep; 32(27):2983-90. PubMed ID: 25071104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of clinical T2N0M0 esophageal cancer.
    Hardacker TJ; Ceppa D; Okereke I; Rieger KM; Jalal SI; LeBlanc JK; DeWitt JM; Kesler KA; Birdas TJ
    Ann Surg Oncol; 2014 Nov; 21(12):3739-43. PubMed ID: 25047477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative Tumor Markers Independently Predict Survival in Stage III Gastric Cancer Patients: Should We Include Tumor Markers in AJCC Staging?
    Lin JX; Wang W; Lin JP; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Zheng CH; Huang CM; Zhou ZW; Li P
    Ann Surg Oncol; 2018 Sep; 25(9):2703-2712. PubMed ID: 29971670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conditional survival after surgical resection of gastric cancer: a multi-institutional analysis of the us gastric cancer collaborative.
    Kim Y; Ejaz A; Spolverato G; Squires MH; Poultsides G; Fields RC; Bloomston M; Weber SM; Votanopoulos K; Acher AW; Jin LX; Hawkins WG; Schmidt C; Kooby D; Worhunsky D; Saunders N; Cho CS; Levine EA; Maithel SK; Pawlik TM
    Ann Surg Oncol; 2015 Feb; 22(2):557-64. PubMed ID: 25287440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of lymph node metastasis correlation with prognosis in patients with T2 gastric cancer.
    Liu X; Long Z; Cai H; Huang H; Shi Y; Wang Y
    PLoS One; 2014; 9(8):e105112. PubMed ID: 25136920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of endoscopic ultrasound in the preoperative staging of gastric cancer: a multi-institutional study of the US gastric cancer collaborative.
    Spolverato G; Ejaz A; Kim Y; Squires MH; Poultsides GA; Fields RC; Schmidt C; Weber SM; Votanopoulos K; Maithel SK; Pawlik TM
    J Am Coll Surg; 2015 Jan; 220(1):48-56. PubMed ID: 25283742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison of the superiority of different TNM staging systems in Siewert III adenocarcinoma of esophagogastric junction].
    Lu Y; Xi H; Xie T; Qiu Z; Wang X; Wei B; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):143-148. PubMed ID: 30799536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival in Patients With Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location.
    Sepesi B; Schmidt HE; Lada M; Correa AM; Walsh GL; Mehran RJ; Rice DC; Roth JA; Vaporciyan AA; Ajani JA; Watson TJ; Swisher SG; Low DE; Hofstetter WL
    Ann Thorac Surg; 2016 Mar; 101(3):1075-80; Discussion 1080-1. PubMed ID: 26680311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.